Melior Discovery

Melior Discovery

Melior Discovery, Inc. is a private biopharmaceutical company based in Exton, Pennsylvania, USA. The company specializes in drug repositioning and has established a technology it uses for this purpose. According to the company’s website, Melior also offers certain contract research organization (CRO) services comprising animal models representing different disease conditions. The Company has issued press releases disclosing partnerships with Pfizer, Merck & Co., Johnson & Johnson and AstraZeneca, all citing the use of the company’s drug repositioning technology. Melior Discovery has also used its technology to discover its own drug candidates. In March 2009 the Food and Drug Administration (FDA) approved the company’s Investigational New Drug (IND) application for a type 2 diabetes therapeutic candidate[1].

Company Information
Type Private
Founded 2005
Industry Biotechnology
Services Biotechnology, contract research organization
Website www.meliordiscovery.com

History

Melior Discovery was co-founded in 2005 by Dr Andrew Reaume (President and CEO) and Dr. Michael Saporito (Vice President of Research) [2]. Its investors include Cammeby’s Capital Group, VenturEast, Osage Ventures, Mid-Atlantic Angel Group, and BioAdvance[3].

References

External links

1. Melior Discovery Website
2. Melior Discovery- Company Profile
3. GEN Article: "Repositioning Idle Drugs via Systematic Serendipity"
4. NGP Article: "Teaching an old drug new tricks…"


Wikimedia Foundation. 2010.

Игры ⚽ Поможем написать реферат

Look at other dictionaries:

  • Nuvelo — Inc. was a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for acute cardiovascular disease, cancer and other debilitating medical conditions. On January 27, 2009, the company was acquired by ARCA… …   Wikipedia

  • Drug repositioning — (also known as Drug repurposing, Drug re profiling, Therapeutic Switching and Drug re tasking) is the application of known drugs and compounds to new indications (i.e., new diseases).[1] Contents 1 Drug repositioning 2 See also …   Wikipedia

  • Myriad Genetics — Type Public Traded as NASDAQ: MYGN) foundation = Salt Lake City, Utah, USA (1992) …   Wikipedia

  • Ortho Pharmaceutical — was initially formed in the United States in 1931 as a subsidiary of Johnson Johnson to market the first prescription spermicidal contraceptive jelly, Ortho Gynol. Contents 1 History 2 See also 3 References …   Wikipedia

  • Cephalon — For information about the head portion in arthropod anatomy, see cephalon (arthropod head). Cephalon, Inc. Type Subsidiary of Teva Pharmaceutical Industries Industry Biotechnology, Biopharmaceutical Founded 1987 Headqu …   Wikipedia

  • OSI Pharmaceuticals — OSI Pharmaceuticals, Inc. Type Subsidiary Industry Biopharmaceuticals Biotherapeutics[1] …   Wikipedia

  • Nereus Pharmaceuticals — is a pharmaceutical company focused on the development of natural products from marine microbial sources into small molecule human therapeutics.[1] The major disease area addressed by Nereus is cancer. As of 2008, Nereus has no marketed products… …   Wikipedia

  • Durata Therapeutics — Durata Therapeutics, established in 2009, is a clinical development stage pharmaceutical company. Durata focuses on new therapeutics to treat infectious diseases. Durata has several projects in its pipeline, most notably the antibacterial,… …   Wikipedia

  • List of pharmaceutical companies — The following is a list of the twelve largest healthcare companies ranked here by revenue as of March 2010[update] according to their released 2009 annual reports. Rank Company Country Total Revenues (USD billions) Total Revenues (reported… …   Wikipedia

  • Johnson & Johnson — Not to be confused with S. C. Johnson Son. Johnson Johnson Type Public Traded as NYSE:  …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”